Global Anti-snoring Device Market 2018-2024

Overview:

Snoring is a harsh noise formed due to the trembling of the muscular palate and pillars of the oropharyngeal inlet during sleep. A person is described as a habitual snorer if there is an occurrence of loud snoring at least three times in a week. This is majorly connected with obstructive sleep apnea (OSA). These habitual snorers experience excessive sleepiness in the daytime and can develop systemic hypertension in those aged below 50 years. Recently, studies have suggested that snoring can have risks of carotid atherosclerosis also. There have been many international epidemiological studies to establish the prevalence of habitual snoring.

When snoring is left untreated, it has multiple adverse consequences such as sleep apnea, stroke, systemic hypertension, atrial fibrillation, coronary artery disease, and others. Anti-snoring devices and surgery are the two types of treatment options available currently. These two methods help in the prevention of snoring and improve the quality of sleep. Uvulopalatopharyngoplasty surgery, radiofrequency ablation surgery, adenoidectomy surgery, maxillo-mandibular surgeries, and tonsillectomy are the alternatives for anti-snoring devices in the market.

The significant factors driving the progress of the market are increasing awareness about ill effects of snoring, mounting geriatric and obese population, increase in the number of smokers and alcoholics, and a huge volume of snoring population. However, the meager effectiveness of present anti-snoring devices accessible in the marketplace and the availability of alternative treatments for snoring are some of the factors hampering the market growth.

Market Analysis: The “Global Anti-snoring Devices Market” is estimated to witness a CAGR of 9.8% during the forecast period 2018–2024. The market is analyzed based on three segments – products, end-users, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). North America holds the major share of the anti-snoring devices market, followed by Europe. These two regions together hold three-fourth of revenue in the market. Asia Pacific is expected to have the fastest growth rate due to high infectious diseases prevalence, large patient pool, and increasing awareness. This is followed by Rest of the World in terms of the growth rate during the forecast period.

Product Analysis: Oral appliances, nasal devices, position control devices, chin straps, and EPAP devices are the types of products in the anti-snoring market. Mandibular advancement devices (MADs) and tongue retaining devices are the types of oral appliances in the market. Nasal dilators and nasal strips are the two types of nasal devices. Position pillows, anti-snoring belt, and bottom lines are the types of position control devices.

End-users Analysis: The hospitals & clinics is the largest application segment in 2017. The sleep clinics that recommend anti-snoring oral appliances to their patients have shown a positive success rate as high as 94%. However, this success rate may vary between individuals. Yet, there has been an increase in the demand for the home healthcare during the forecast period. This increase in home care has given rise to many technological advanced and portable products.

Key Players: Sleeping Well LLC, Apnea Sciences Corporation, Tomed GmbH, Sleep Well Enjoy Life Ltd., MEDiTAS, and GlaxoSmithKline are the key players in the market. SomnoMed Ltd., MPowerx, Thervent, Rhinomed Ltd., Hivox Biotek Inc., and Zyppah are other predominate & niche players.

Competitive Analysis: The oral appliances are the most used anti-snoring devices and held more than half of the share in 2017. Some of the key players in this segment include Apnea Sciences Corporation, Sleeping Well, Sleep Well Enjoy Life, Tomed GmbH, and MEDiTAS. Nasal devices are next to the oral appliances, which is led by GlaxoSmithKline.

Many companies are concentrating on product innovation to reinforce their spot in the market. For instance, Oventus Medical, based in Australia, has recently launched a 3D printed anti-snoring device named O2Vent that can be customized based on an individual’s need. It is a lightweight titanium device and can help patients stop snoring by delivering air to the back of his or her mouth. Such modernizations hold the great potential for the success of the company in the market.

Benefits: The report provides complete details about the usage and adoption rate of anti-snoring devices in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, and vertical player’s initiatives. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders:

anti snoring device stakeholders

1              Industry Outlook

1.1          Industry Overview

1.2          Industry Trends

2              Report Outline

2.1          Report Scope

2.2          Report Summary

2.3          Research Methodology

2.4          Report Assumptions

3              Market Snapshot

3.1          Segmented Addressable Market

3.2          Industry Trends

3.3          Related Markets

3.3.1      Nebulizers

3.3.2      Continuous positive airway pressure (CPAP)

3.3.3      Sleep Apnea

3.3.4      Pulmonary Medicine

4              Market Outlook              

4.1          Market Definition – Infoholic Research

4.2          Market Overview

4.3          Causes of Snoring

4.4          Market Segmentation

4.5          Porter 5(Five) Forces

4.6          PEST Analysis

5              Market Characteristics

5.1          Market Dynamics

5.1.1      Drivers

5.1.1.1   Increasing usage of oral appliances

5.1.1.2   Growing awareness about ill-effects of snoring

5.1.1.3   High prevalence of tobacco smoking

5.1.1.4   In expensive nature of the devices

5.1.2      Opportunities

5.1.2.1   Rising Ageing and Obese Population

5.1.2.2   Emerging Markets in Developing Countries

5.1.3      Restraints

5.1.3.1   Poor Effectiveness of Existing Anti-Snoring Devices in The Market

5.1.3.2   Alternative Treatment for Snoring

5.2          DRO – Impact Analysis

5.3          Key Stakeholders

6              Product: Market Size and Analysis

6.1          Overview

6.2          Oral Appliances 30

6.2.1      Mandibular Advancement Devices (MAD)

6.2.2      Tongue Stabilizing Devices

6.3          Nasal Devices

6.3.1      Nasal Dilator

6.3.2      Nasal Strips

6.4          Position Control Devices

6.5          Chin Straps

6.6          EPAP Therapy Devices

7              End-users: Market Size and Analysis

7.1          Overview

7.2          Hospitals and clinics

7.3          Home Care

8              Regions: Market Size and Analysis

8.1          Overview

8.2          North America

8.2.1      Overview

8.2.2      United States

8.2.3      Canada

8.3          Europe

8.3.1      Overview

8.3.2      UK

8.3.3      Germany

8.3.4      France

8.4          Asia Pacific

8.4.1      Overview

8.4.2      India

8.4.3      Japan

8.4.4      China

8.4.5      Australia

8.5          Rest of the World

8.5.1      Overview

8.5.2      Brazil

8.5.3      Middle East

9              Competitive Landscape

10           Vendors Profile

10.1        GlaxoSmithKline plc

10.1.1    Overview

10.1.2    Geographic Presence

10.1.3    Business Focus

10.1.4    SWOT Analysis

10.1.5    Business Strategy

10.2        Meditas

10.2.1    Overview

10.3        Sleeping Well LLC

10.3.1    Overview

10.4        Apnea Sciences Corporation

10.4.1    Overview

10.5        SomnoMed Ltd.

10.5.1    Overview

10.6        Tomed GmbH

10.6.1    Overview

10.7        MPowerx

10.7.1    Overview

10.8        Theravent

10.8.1    Overview

10.9        Sleep Well Enjoy Life Ltd

10.9.1    Overview

10.10     Rhinomed Ltd

10.10.1  Overview

10.10.2  Highlights

10.11     Hivox Biotek Inc.

10.11.1  Overview

10.12     ZYPPAH

10.12.1  Overview

Annexure

Abbreviations

Infoholic research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:

  • Data Collation (Secondary & Primary)
  • In-house Estimation (Based on proprietary data bases and Models)
  • Market Triangulation
  • Forecasting

methodology

Market related information is congregated from both secondary and primary sources. Secondary sources include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.

Primary sources involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.

For more details on Research Methodology kindly click here to Engage with our Analyst.

market research pricing and licence option

  • 10
    Enquiry Hours